It’s all relative Apria vent revenues went down during Q3, VMD vent revenues went up.
Apria Q3
Home respiratory therapy. Net revenues increased 4.2% primarily due to increased volume of patients requiring oxygen therapy during the COVID-19 pandemic and higher reimbursement levels. The increase was partially offset by lower ventilation therapy revenues due to a reduction in the commencement of new services during the COVID-19 pandemic, as well as, equipment shortages resulting from the Recall.